Elsevier

Drug and Alcohol Dependence

Volume 81, Issue 2, 1 February 2006, Pages 167-178
Drug and Alcohol Dependence

Unmet need for recommended preventive health services among clients of California syringe exchange programs: Implications for quality improvement

https://doi.org/10.1016/j.drugalcdep.2005.06.008Get rights and content

Abstract

Background

Comprehensive preventive services are recommended for injection drug users (IDU), including screening tests, vaccinations, risk reduction counseling, and sterile syringes. Syringe exchange programs (SEP) may facilitate receipt of preventive services by IDUs, but whether SEP clients receive recommended preventive care is not known. We examined use of recommended preventive services by clients of 23 SEPs throughout California.

Methods

Five hundred and sixty SEP clients were recruited from 23 SEPs throughout California between March and September 2003. Receipt of 10 recommended preventive services and source of care (SEP versus non-SEP providers) was ascertained from client interviews.

Results

On average, SEP clients received only 13% of recommended preventive services and 49% of clients received none of the recommended services. Of services that were received, 76% were received from SEPs. In multivariate analysis, use of drug treatment and more frequent SEP visits were associated with receipt of recommended preventive services by clients.

Conclusions

SEPs are often the only source of preventive care for their IDU clients. Still, SEP clients fail to receive most recommended preventive services. Interventions to increase use of preventive services and improve the quality of preventive care received by IDUs, such as increased access to drug treatment and SEPs, are needed.

Introduction

Injection drug users (IDU) suffer high morbidity and mortality due to preventable conditions, including human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), sexually transmitted infections (STIs), tuberculosis (TB), and accidental overdose (Kral et al., 2003, Kral et al., 2004, Kuo et al., 2004, Friedman et al., 2003, Murrill et al., 2002, Seal et al., 2001, Davidson et al., 2003, Coffin et al., 2003; CDCP, 2003b, CDCP, 2004; Perlman et al., 1995). In the United States (US), the Centers for Disease Control and Prevention (CDC) recommends that IDUs receive comprehensive preventive services to address these multiple sources of risk, including screening for infectious diseases, vaccinations, risk reduction counseling, drug treatment/counseling, and access to sterile syringes (Academy for Educational Development, 2000). Yet, these preventive services cannot result in improvements in health if at-risk IDUs do not receive them.

Recent studies have documented significant deficits in the quality of care provided by the US health care system (Schuster et al., 1998), with Americans receiving on average only about 50% of recommended preventive services (McGlynn et al., 2003). While the quality of preventive care received by vulnerable populations such as IDUs has not been systematically evaluated, there is reason to believe that IDUs may fail to receive recommended preventive care. For example, IDUs have poor access to traditional sources of preventive care, including primary care providers (Chitwood et al., 1999, Chitwood et al., 2001, Chitwood et al., 2002, French et al., 2000, Riley et al., 2002c) and drug treatment programs (Wenzel et al., 2001, Wu et al., 2003). And although providers have adopted a variety of low threshold community-based approaches to delivering preventive services to marginalized IDUs, including providing preventive services via street outreach, and at homeless shelters, drop-in centers, and syringe exchange programs (SEPs), few studies have determined if IDUs using these low threshold services are receiving recommended preventive care. As a result, studies to identify unmet need for preventive care among IDUs, as well as successful strategies for delivering preventive services to IDUs, are needed.

Of low threshold providers, SEPs, which distribute sterile syringes to IDUs in order to reduce HIV transmission via syringe sharing, are uniquely positioned to deliver preventive services to IDUs due to their ability to successfully attract highly marginalized IDUs with frequent high-risk behaviors (Hahn et al., 1997, Hagan et al., 2000, Miller et al., 2002) and therefore high need for preventive care. While multiple studies have established the effectiveness of SEPs in preventing transmission of HIV via syringe sharing (Gibson et al., 2001), less is known about the role of SEPs in providing preventive services to IDUs.

Previous studies evaluating preventive services available at selected SEPs have found delivery of preventive services to IDUs at SEPs to be feasible and effective, including vaccinations (Stancliff et al., 2000, Des Jarlais et al., 2001), screening for HIV and STIs (Liebman et al., 2002), and screening for tuberculosis (Perlman et al., 1997, Perlman et al., 2001, Riley et al., 2002b). But other studies suggest that these findings may not be generalizable to SEPs and IDUs in other communities. For example, a national survey of US SEPs found that availability of preventive services at SEPs varies, with on-site HIV testing and counseling available at 64% of SEPs, but HCV testing available at only 24% of SEPs, HBV vaccinations at only 16%, and STI testing at only 13% (Centers for Disease Control and Prevention, 2001). While SEP preventive services may be potentially effective, IDUs may still fail to receive needed services if services are not available from the SEP and are not received from other sources, suggesting that additional studies examining use of preventive services among IDUs from multiple SEPs, and including services from SEPs and non-SEP sources, are needed. In addition, a study comparing use of a variety of preventive services among SEP clients and methadone maintenance patients in Rhode Island found that although the majority of IDUs in both groups had received screening for HIV and TB, many SEP clients had not received testing for HCV, HBV, and STIs or vaccination against HBV (McGarry et al., 2002). Previous studies have focused on selected preventive services and therefore studies examining a variety of preventive services are necessary in order to insure that IDUs receive the comprehensive preventive care that is recommended. Finally, little is known about factors that may facilitate use of preventive services among IDUs, such as use of primary care or drug treatment services, or more frequent SEP visits, which may provide greater access to preventive services provided at the SEP. Studies to identify these factors are needed in order to best design interventions to increase use of preventive services and improve the quality of preventive care received by IDUs.

In order to address these gaps in the literature we asked the following research questions using data from a sample of clients from 23 SEPs throughout California: Do SEP clients receive recommended preventive services from any source, including SEPs and non-SEP sources? What portion of recommended services are received from SEPs versus from non-SEP sources? Are specific services more likely to be underused? Are SEP client characteristics, specifically having health insurance, use of primary care or drug treatment, or more frequent SEP visits, associated with receipt of recommended preventive services, after controlling for demographics, drug use, and risk behaviors?

Section snippets

Participants and data collection

Data for this paper came from a larger study of changes in statewide policy regarding legalization of SEPs in California (Riehman et al., 2004). A convenience sample of 560 SEP clients was recruited from 23 SEPs throughout California (approximately 25 clients per SEP) from March to September 2003. The 23 SEPs in the study represent approximately two-thirds of California SEPs in 2003, and all but one were in existence in 2000 when the larger study began. The SEPs were located in 16 different

Characteristics of sample

SEPs in the study included a variety of different organization types and ranged from very small programs with several hundred client contacts to very large programs exchanging more than 500,000 syringes per year (Table 2). The mean age of SEP clients in the sample was 43 years (standard deviation 10.7 years), 68% were male, 51% were white, 51% reported current homelessness and 56% were uninsured. The majority reported injecting heroin (76%) but use of other drugs was also common. A considerable

Discussion

Multiple studies support the effectiveness of preventive health services in preventing harmful consequences of injection drug use. Yet, effective services will not result in improved community health if IDUs in these communities do not receive needed services. We examined use of preventive services among IDUs using SEPs in California, and found that despite high need for preventive services, SEP clients failed to receive the majority of recommended preventive services, with unmet need for

Acknowledgements

The authors would like to thank the Centers for Disease Control and Prevention for funding the California Syringe Exchange Program Study (Grant #RO6/CCR918667). Support for writing this paper was also provided by the National Institute on Drug Abuse (Grant #R01DA14210), the Universitywide AIDS Research Program (Grant #IS02-DREW-705) and the Robert Wood Johnson/VA Clinical Scholars Program. The authors also thank the following project staff: Christopher Buck and Ellyn Bloomfield in Santa Monica

References (94)

  • K.H. Seal et al.

    A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users

    Drug Alcohol Depend.

    (2003)
  • S. Stancliff et al.

    Provision of influenza and pneumococcal vaccines to injection drug users at a syringe exchange

    J. Subst. Abuse Treat.

    (2000)
  • A Comprehensive Approach: Preventing Blood-borne Infections Among Injection Drug Users

    (2000)
  • F.L. Altice et al.

    Adherence to hepatitis B virus vaccination at syringe exchange sites

    J. Urban Health

    (2005)
  • R.N. Bluthenthal et al.

    Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco

    Med. Anthropol.

    (1997)
  • O.O. Bolu et al.

    Is HIV/sexually transmitted disease prevention counseling effective among vulnerable populations?: a subset analysis of data collected for a randomized, controlled trial evaluating counseling efficacy (Project RESPECT)

    Sex. Transm. Dis.

    (2004)
  • R. Brooner et al.

    Drug abuse treatment success among needle exchange participants

    Public Health Rep.

    (1998)
  • D.A. Bux et al.

    Participation in an outreach-based coupon distribution program for free methadone detoxification

    Hosp. Community Psychiatry

    (1993)
  • P. Case et al.

    Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention

    J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.

    (1998)
  • Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

    MMWR Recomm. Rep.

    (1998)
  • Update: syringe exchange programs—United States, 1998

    MMWR Morb. Mortal. Wkly. Rep.

    (2001)
  • Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention

    MMWR Recomm. Rep.

    (2002)
  • Advancing HIV prevention: new strategies for a changing epidemic—United States, 2003

    MMWR Morb. Mortal. Wkly. Rep.

    (2003)
  • HIV diagnoses among injection-drug users in states with HIV surveillance—25 states, 1994–2000

    MMWR Morb. Mortal. Wkly. Rep.

    (2003)
  • Incidence of acute hepatitis B—United States, 1990–2002

    MMWR Morb. Mortal. Wkly. Rep.

    (2004)
  • Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)

    MMWR Recomm. Rep.

    (1991)
  • D.D. Chitwood et al.

    Satisfaction with access to health care among injection drug users, other drug users, and nonusers

    J. Behav. Health Serv. Res.

    (2002)
  • D.D. Chitwood et al.

    Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers

    Subst. Use Misuse

    (1999)
  • D.D. Chitwood et al.

    Primary preventive health care among injection drug users, other sustained drug users, and non-users

    Subst. Use Misuse

    (2001)
  • P.O. Coffin et al.

    Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–1998

    Addiction

    (2003)
  • S.L. Coyle et al.

    Outreach-based HIV prevention for injecting drug users: a review of published outcome data

    Public Health Rep.

    (1998)
  • P.J. Davidson et al.

    Fatal heroin-related overdose in San Francisco, 1997–2000: a case for targeted intervention

    J. Urban Health

    (2003)
  • D.C. Des Jarlais et al.

    Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program

    Am. J. Public Health

    (2001)
  • D.C. Des Jarlais et al.

    Public funding of US syringe exchange programs

    J. Urban Health

    (2004)
  • A.V. Diez-Roux

    Multilevel analysis in public health research

    Annu. Rev. Public Health

    (2000)
  • G. D'Souza et al.

    Cross-sectional survey of the extent and indicators of hepatitis C virus infection in Houston Department of Health and Human Services’ sexually transmitted disease clinics

    J. Viral Hepat.

    (2003)
  • R. Finkelstein et al.

    Manual for Primary Care Providers: Effectively Caring for Active Substance Users

    (2002)
  • R. Finkelstein et al.

    Towards a Comprehensive Plan for Syringe Exchange in New York City

    (2000)
  • S.R. Friedman et al.

    Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City

    Addiction

    (2003)
  • P.D. Friedmann et al.

    On-site primary care and mental health services in outpatient drug abuse treatment units

    J. Behav. Health Serv. Res.

    (1999)
  • P.D. Friedmann et al.

    Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?

    Health Serv. Res.

    (2000)
  • P.D. Friedmann et al.

    Linkage to medical services in the Drug Abuse Treatment Outcome Study

    Med. Care

    (2001)
  • R.S. Garfein et al.

    Prevalence and incidence of hepatitis C virus infection among young adult injection drug users

    J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.

    (1998)
  • L. Gelberg et al.

    The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people

    Health Serv. Res.

    (2000)
  • D.R. Gibson et al.

    Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users

    AIDS

    (2001)
  • D.R. Gibson et al.

    Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users

    AIDS

    (1998)
  • H. Hagan et al.

    Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs

    J. Urban Health

    (2000)
  • Cited by (0)

    View full text